Tuberculosis after anti-TNF therapy.
Pamuk
Omer Nuri
ON
Dönmez
Salim
S
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use; D000075202:Contraindications; D006801:Humans; D000069285:Infliximab; D012307:Risk Factors; D012595:Scleroderma, Systemic / Q000188:drug therapy; D014376:Tuberculosis / Q000453:epidemiology*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab